JP2016528174A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016528174A5 JP2016528174A5 JP2016517040A JP2016517040A JP2016528174A5 JP 2016528174 A5 JP2016528174 A5 JP 2016528174A5 JP 2016517040 A JP2016517040 A JP 2016517040A JP 2016517040 A JP2016517040 A JP 2016517040A JP 2016528174 A5 JP2016528174 A5 JP 2016528174A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- cdp
- conjugate
- jak inhibitor
- jak
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361829797P | 2013-05-31 | 2013-05-31 | |
| US61/829,797 | 2013-05-31 | ||
| PCT/US2014/040230 WO2014194195A2 (en) | 2013-05-31 | 2014-05-30 | Cyclodextrin-based polymers for the therapeutic delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016528174A JP2016528174A (ja) | 2016-09-15 |
| JP2016528174A5 true JP2016528174A5 (enExample) | 2017-07-13 |
Family
ID=51985801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517040A Pending JP2016528174A (ja) | 2013-05-31 | 2014-05-30 | 治療的送達用のシクロデキストリンベースのポリマー |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20140357557A1 (enExample) |
| JP (1) | JP2016528174A (enExample) |
| AU (1) | AU2014273983A1 (enExample) |
| CA (1) | CA2913752A1 (enExample) |
| WO (1) | WO2014194195A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105924444B (zh) * | 2015-03-11 | 2019-06-18 | 苏州晶云药物科技股份有限公司 | Jak抑制剂的晶型及其制备方法 |
| CN104987333B (zh) * | 2015-07-14 | 2017-01-11 | 苏州富士莱医药股份有限公司 | 一种Filgotinib的合成方法 |
| ES2973564T3 (es) * | 2015-09-28 | 2024-06-20 | Cti Biopharma Corp | Tratamiento o prevención de enfermedad de injerto contra huésped |
| CA3000951A1 (en) * | 2015-10-20 | 2017-04-27 | Emory University | Response-guided hcv therapy |
| RS60237B1 (sr) | 2015-11-24 | 2020-06-30 | Theravance Biopharma R&D Ip Llc | Prolekovi jak inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti |
| WO2017177055A1 (en) * | 2016-04-08 | 2017-10-12 | Liang Zhao | Cyclodextrin-based polymers for therapeutic delivery |
| JP2020502126A (ja) * | 2016-12-14 | 2020-01-23 | プロジェニティ， インコーポレイテッド | 消化管疾病のｊａｋ阻害薬による治療 |
| CN110418796A (zh) * | 2017-03-08 | 2019-11-05 | 施万生物制药研发Ip有限责任公司 | 托法替尼(tofacitinib)的葡萄糖苷酸前药 |
| EP3595699A4 (en) * | 2017-03-16 | 2020-12-23 | Blaze Bioscience, Inc. | PEPTIDIC CONJUGATES OF CARTILAGE ECOTROPISM AND THEIR METHODS OF USE |
| PH12019502605A1 (en) | 2017-05-23 | 2020-10-26 | Theravance Biopharma R&D Ip Llc | Glucuronide prodrugs of janus kinase inhibitors |
| EP3609903A1 (en) * | 2017-05-23 | 2020-02-19 | Theravance Biopharma R&D IP, LLC | Thiocarbamate prodrugs of tofacitinib |
| WO2019089962A1 (en) * | 2017-11-03 | 2019-05-09 | Osteoanalgesia, Llc | Drug delivery system for treating disease |
| US20210015933A1 (en) * | 2018-03-30 | 2021-01-21 | Seikagaku Corporation | Bioactive carboxylic acid type compound-polymer conjugate, and method for manufacturing the same |
| US10912759B2 (en) * | 2018-05-17 | 2021-02-09 | William Andrew Clark | Topical gel compositions for the treatment of Staphylococcal infections |
| CN111094314B (zh) * | 2018-08-15 | 2022-08-12 | 江苏豪森药业集团有限公司 | 含有葡糖苷酸衍生物jak抑制剂的前药及其制备方法和应用 |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| CN110403944A (zh) * | 2019-08-07 | 2019-11-05 | 中南大学湘雅医院 | Decernotinib在制备治疗银屑病的外用药物中的应用、药物及制备方法 |
| US12441707B2 (en) | 2019-12-30 | 2025-10-14 | Tyra Biosciences, Inc. | Indazole compounds |
| EP3944859A1 (en) | 2020-07-30 | 2022-02-02 | Assistance Publique Hôpitaux de Paris | Method for treating immune toxicities induced by immune checkpoint inhibitors |
| CN117355527B (zh) * | 2021-07-20 | 2024-06-07 | 上海椿安生物医药科技有限公司 | 一种消炎偶联化合物药物及其制法和应用 |
| AU2022342078A1 (en) * | 2021-09-09 | 2024-01-25 | Bt Bidco, Inc. | Aqueous formulations of tofacitinib and tofacitinib salts |
| JP2025505812A (ja) * | 2022-02-21 | 2025-02-28 | オンクオリティ ファーマシューティカルズ チャイナ リミテッド | 化合物及びその用途 |
| WO2023244611A1 (en) * | 2022-06-13 | 2023-12-21 | Emory University | Uses of jak inhibitors in the management of inflammation-associated depression and central nervous system (cns) pathologies |
| WO2025040148A1 (zh) * | 2023-08-22 | 2025-02-27 | 北京普祺医药科技股份有限公司 | 一种用于jak抑制剂的外用凝胶及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7897568B2 (en) * | 2006-03-03 | 2011-03-01 | Vinay K. Singh | Compositions for treatment of cancer |
| CN102781237A (zh) * | 2009-11-23 | 2012-11-14 | 天蓝制药公司 | 用于传递治疗剂的基于环糊精的聚合物 |
| WO2012003457A1 (en) * | 2010-07-01 | 2012-01-05 | Mtm Research Llc | Anti-fibroblastic fluorochemical emulsion therapies |
| US20120213854A1 (en) * | 2010-09-30 | 2012-08-23 | Fetzer Oliver S | Methods of treating a subject and related particles, polymers and compositions |
| EP2463289A1 (en) * | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
-
2014
- 2014-05-30 US US14/291,745 patent/US20140357557A1/en not_active Abandoned
- 2014-05-30 JP JP2016517040A patent/JP2016528174A/ja active Pending
- 2014-05-30 WO PCT/US2014/040230 patent/WO2014194195A2/en not_active Ceased
- 2014-05-30 AU AU2014273983A patent/AU2014273983A1/en not_active Abandoned
- 2014-05-30 CA CA2913752A patent/CA2913752A1/en not_active Abandoned
-
2017
- 2017-07-11 US US15/646,584 patent/US20180117168A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016528174A5 (enExample) | ||
| Birke et al. | Polypeptoid-block-polypeptide copolymers: Synthesis, characterization, and application of amphiphilic block copolypept (o) ides in drug formulations and miniemulsion techniques | |
| ES2510396T3 (es) | Direccionamiento a células de cáncer usando nanopartículas | |
| CN101541347B (zh) | 药物载体、其合成及其使用方法 | |
| Moore et al. | Multifunctional polymer‐coated carbon nanotubes for safe drug delivery | |
| ES2525257T3 (es) | Composiciones de ciclopolisacárido y de bendamustina | |
| JP2016153410A5 (enExample) | ||
| JP2017511322A5 (enExample) | ||
| JP2015528002A5 (enExample) | ||
| JP2017505104A5 (enExample) | ||
| JP2014531476A5 (enExample) | ||
| JP2015532295A5 (enExample) | ||
| JP2011523643A5 (enExample) | ||
| JP2011530597A5 (enExample) | ||
| JP2018510863A5 (enExample) | ||
| JP2019512006A5 (enExample) | ||
| Gadde et al. | Development of therapeutic polymeric nanoparticles for the resolution of inflammation | |
| JP2019523761A5 (enExample) | ||
| JP2001514167A5 (enExample) | ||
| JP2012503603A5 (enExample) | ||
| JP2013518905A5 (enExample) | ||
| US20220054659A1 (en) | Psma-targeted pamam dendrimers for specific delivery of imaging, contrast and therapeutic agents | |
| JP2010513441A5 (enExample) | ||
| JP2020519676A5 (enExample) | ||
| JP2012504608A5 (enExample) |